vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Fiverr International Ltd. (FVRR). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $287.8M, roughly 1.7× Fiverr International Ltd.). Fiverr International Ltd. runs the higher net margin — 1.9% vs -10.1%, a 12.0% gap on every dollar of revenue. Fiverr International Ltd. produced more free cash flow last quarter ($52.1M vs $-69.0M). Over the past eight quarters, Fiverr International Ltd.'s revenue compounded faster (29.5% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Fiverr International Ltd. operates a global online freelance services marketplace connecting businesses and independent creators across over 160 countries. It offers services covering digital marketing, graphic design, programming, writing, video editing, and other professional fields, catering to SMEs, startups, and enterprise clients needing flexible on-demand talent solutions.

CLOV vs FVRR — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.7× larger
CLOV
$487.7M
$287.8M
FVRR
Higher net margin
FVRR
FVRR
12.0% more per $
FVRR
1.9%
-10.1%
CLOV
More free cash flow
FVRR
FVRR
$121.0M more FCF
FVRR
$52.1M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
FVRR
FVRR
Annualised
FVRR
29.5%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLOV
CLOV
FVRR
FVRR
Revenue
$487.7M
$287.8M
Net Profit
$-49.3M
$5.4M
Gross Margin
82.5%
Operating Margin
-10.1%
-3.5%
Net Margin
-10.1%
1.9%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
FVRR
FVRR
Q4 25
$487.7M
Q3 25
$496.6M
$287.8M
Q2 25
$477.6M
$188.2M
Q1 25
$462.3M
$93.5M
Q4 24
$337.0M
Q3 24
$331.0M
$269.9M
Q2 24
$356.3M
$177.3M
Q1 24
$346.9M
$88.0M
Net Profit
CLOV
CLOV
FVRR
FVRR
Q4 25
$-49.3M
Q3 25
$-24.4M
$5.4M
Q2 25
$-10.6M
$4.1M
Q1 25
$-1.3M
$788.0K
Q4 24
$-22.1M
Q3 24
$-9.2M
$-1.0M
Q2 24
$7.4M
$-4.0M
Q1 24
$-19.2M
$-4.3M
Gross Margin
CLOV
CLOV
FVRR
FVRR
Q4 25
Q3 25
82.5%
Q2 25
83.3%
Q1 25
83.5%
Q4 24
Q3 24
24.5%
82.8%
Q2 24
30.3%
82.4%
Q1 24
23.6%
82.2%
Operating Margin
CLOV
CLOV
FVRR
FVRR
Q4 25
-10.1%
Q3 25
-4.9%
-3.5%
Q2 25
-2.2%
-3.4%
Q1 25
-0.3%
-4.4%
Q4 24
-6.4%
Q3 24
-2.7%
-5.0%
Q2 24
2.0%
-6.3%
Q1 24
-6.5%
-8.1%
Net Margin
CLOV
CLOV
FVRR
FVRR
Q4 25
-10.1%
Q3 25
-4.9%
1.9%
Q2 25
-2.2%
2.2%
Q1 25
-0.3%
0.8%
Q4 24
-6.6%
Q3 24
-2.8%
-0.4%
Q2 24
2.1%
-2.3%
Q1 24
-5.5%
-4.9%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
FVRR
FVRR
Cash + ST InvestmentsLiquidity on hand
$78.3M
$133.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$362.6M
Total Assets
$541.0M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
FVRR
FVRR
Q4 25
$78.3M
Q3 25
$133.5M
Q2 25
$578.4M
Q1 25
$133.5M
Q4 24
$194.5M
Q3 24
$288.0M
$183.7M
Q2 24
$254.8M
$183.7M
Q1 24
$208.3M
$183.7M
Stockholders' Equity
CLOV
CLOV
FVRR
FVRR
Q4 25
$308.7M
Q3 25
$340.9M
$362.6M
Q2 25
$344.2M
$404.9M
Q1 25
$336.1M
$362.6M
Q4 24
$341.1M
Q3 24
$342.2M
$355.8M
Q2 24
$324.9M
$355.8M
Q1 24
$292.5M
$355.8M
Total Assets
CLOV
CLOV
FVRR
FVRR
Q4 25
$541.0M
Q3 25
$559.7M
$1.1B
Q2 25
$575.0M
$1.1B
Q1 25
$583.7M
$1.1B
Q4 24
$580.7M
Q3 24
$653.0M
$1.0B
Q2 24
$674.2M
$1.0B
Q1 24
$671.8M
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
FVRR
FVRR
Operating Cash FlowLast quarter
$-66.9M
$53.0M
Free Cash FlowOCF − Capex
$-69.0M
$52.1M
FCF MarginFCF / Revenue
-14.1%
18.1%
Capex IntensityCapex / Revenue
0.4%
0.3%
Cash ConversionOCF / Net Profit
9.81×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$124.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
FVRR
FVRR
Q4 25
$-66.9M
Q3 25
$12.1M
$53.0M
Q2 25
$5.4M
$42.2M
Q1 25
$-16.3M
$21.2M
Q4 24
$34.8M
Q3 24
$50.0M
$10.9M
Q2 24
$44.8M
$32.2M
Q1 24
$25.9M
$21.2M
Free Cash Flow
CLOV
CLOV
FVRR
FVRR
Q4 25
$-69.0M
Q3 25
$11.4M
$52.1M
Q2 25
$4.8M
$41.5M
Q1 25
$-16.5M
$20.8M
Q4 24
$33.3M
Q3 24
$49.6M
$10.6M
Q2 24
$44.4M
$31.5M
Q1 24
$25.5M
$20.8M
FCF Margin
CLOV
CLOV
FVRR
FVRR
Q4 25
-14.1%
Q3 25
2.3%
18.1%
Q2 25
1.0%
22.0%
Q1 25
-3.6%
22.3%
Q4 24
9.9%
Q3 24
15.0%
3.9%
Q2 24
12.5%
17.8%
Q1 24
7.3%
23.7%
Capex Intensity
CLOV
CLOV
FVRR
FVRR
Q4 25
0.4%
Q3 25
0.1%
0.3%
Q2 25
0.1%
0.4%
Q1 25
0.0%
0.4%
Q4 24
0.5%
Q3 24
0.1%
0.1%
Q2 24
0.1%
0.4%
Q1 24
0.1%
0.4%
Cash Conversion
CLOV
CLOV
FVRR
FVRR
Q4 25
Q3 25
9.81×
Q2 25
10.40×
Q1 25
26.90×
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons